Glycated albumin is probably the best serum protein to measure since it is present in high concentrations and has a half-life of about 19 days. It also has a potential advantage over haemoglobin since it is not contained within a cell.
Abbreviations used: ELISA, enzyme-linked immunosorbent assay; TMB, tetramethylhenzidinc. Therefore, it is not subject t o variation in intracellular factors which may affect the rate of glycation of haemoglobin.
Several groups have successfully raised antisera t o sodium borohydride-reduced glycated albumin. However, immunoassays based on these antisera not only require reduction of the sample, but also removal of the reducing agent, before analysis. Therefore, although glycated proteins are known t o be poor immunogens 141, we decided to produce antisera which would recognize the natural glycated epitope and thus avoid the extra steps in sample preparation in the previously mentioned assays.
Initially, several glycated compounds were synthesized and used t o raise antisera in sheep to naturally glycated serum proteins. These were assessed by an enzyme-linked immunosorbent assay (ELISA) using microtitration plates which had previously been coated with the corresponding antigen. T h e amount of antibody which bound t o the coat was determined with horseradish peroxidase-labelled donkey anti-sheep IgG using tetramethylbenzidine (TMB) as the substrate. Titres were found to be in the range of 4-90 K. T h e specificity of one of these antisera. codc 9 I S/IE, after boosting is presented below.
This antisera had a titre 1 / I00 000 and showed considcrable displacement of the antiserum dilution curve when incybated with diabetic plasma indicating that it was of high , and plasma pretreated with sodium borohydride (track 2) using affinity-purified antibodies t o glycated HSA.
avidity. An affinity column of immobilized, naturally glycated human serum albumin was used t o isolate antibodies to the glycated epitopc. An indirect competitive ELlSA for human serum albumin was developed, where the sample was preincubated with the affinity-purified antibody. Aliquots o f the incubation mixture were added to the wells of a microtitration plate (Dynatech PVC Immunolon) which had been coated with antigen. T h e amount of antibody bound was determined with horseradish peroxidase-labelled donkey anti-sheep IgG using T M B as substrate. T h e dynamic range of the assay was from 0 to 100 pg/ml of glycated human serum albumin. Cross-reactivity was assessed using the same assay. Both sodium periodateand sodium borohydride-treated glycated human serum albumin exhibited less than 0.1 5% cross-reactivity (Fig. 1 u) .
These treatments both destroy the fructosamine structure on the protein and hence the epitope. Fig. 1 ( u ) also shows that of the other compounds tested, fructose exhibited only negligible cross-reactivity at 0.000 1 S%.
T h e specificity o f the affinity-purified antibodies was also chcckcd by Western blot analysis. This demonstrated that the antibodies recognized a continuous epitope on a single protein in human serum 151. This had a size of 68 kDa, i.e. compatible with being human serum albumin. This recognition was destroyed if the serum was pretreated with sodium borohydride (Fig. 1 h) .
This novel antiserum is now being used to develop a simple immunometric assay for glycated human serum albumin.
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